iShares Genomics Immunology and Healthcare ETF (IDNA)

Assets	$164.64M
Expense Ratio	0.47%
PE Ratio	16.27
Shares Out	5.45M
Dividend (ttm)	$0.31
Dividend Yield	1.06%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Semi-Annual
Payout Ratio	17.21%

Volume	39,578
Open	29.91
Previous Close	29.96
Day's Range	29.10 - 29.91
52-Week Low	20.15
52-Week High	31.41
Beta	0.95
Holdings	65
Inception Date	Jun 11, 2019

About IDNA

Fund Home Page

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: IDNA
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

48.63% of assets

Name	Symbol	Weight
Revolution Medicines, Inc.	RVMD	7.32%
Moderna, Inc.	MRNA	6.97%
Ipsen S.A.	IPN	4.73%
Twist Bioscience Corporation	TWST	4.73%
Merck & Co., Inc.	MRK	4.51%
Exelixis, Inc.	EXEL	4.43%
Takeda Pharmaceutical Company Limited	4502	3.99%
Bayer Aktiengesellschaft	BAYN	3.99%
Roche Holding AG	ROP	3.99%
GSK plc	GSK	3.97%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.15546	Dec 19, 2025
Jun 16, 2025	$0.15291	Jun 20, 2025
Dec 17, 2024	$0.11105	Dec 20, 2024
Jun 11, 2024	$0.11144	Jun 17, 2024
Dec 20, 2023	$0.16925	Dec 27, 2023
Jun 7, 2023	$0.07077	Jun 13, 2023

Performance

IDNA had a total return of 41.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.24%.